日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Xenotropic murine leukemia virus-related virus is not associated with chronic fatigue syndrome in patients from different areas of the us in the 1990s

20世纪90年代,异嗜性鼠白血病病毒相关病毒与美国不同地区患者的慢性疲劳综合征无关。

Ali, Mir A; Dale, Janet K; Kozak, Christine A; Goldbach-Mansky, Raphaela; Miller, Frederick W; Straus, Stephen E; Cohen, Jeffrey I

A real-time PCR assay to identify and discriminate among wild-type and vaccine strains of varicella-zoster virus and herpes simplex virus in clinical specimens, and comparison with the clinical diagnoses

一种用于鉴定和区分临床标本中水痘-带状疱疹病毒和单纯疱疹病毒野生型和疫苗株的实时PCR检测方法,并与临床诊断进行比较。

Harbecke, Ruth; Oxman, Michael N; Arnold, Beth A; Ip, Charlotte; Johnson, Gary R; Levin, Myron J; Gelb, Lawrence D; Schmader, Kenneth E; Straus, Stephen E; Wang, Hui; Wright, Peter F; Pachucki, Constance T; Gershon, Anne A; Arbeit, Robert D; Davis, Larry E; Simberkoff, Michael S; Weinberg, Adriana; Williams, Heather M; Cheney, Carol; Petrukhin, Luba; Abraham, Katalin G; Shaw, Alan; Manoff, Susan; Antonello, Joseph M; Green, Tina; Wang, Yue; Tan, Charles; Keller, Paul M

Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs

在 HSV-1 血清阳性和 HSV-1 血清阴性豚鼠中,使用复制缺陷型 HSV-2 或糖蛋白 D2 疫苗对单纯疱疹病毒 (HSV)-2 感染的保护作用

Hoshino, Yo; Pesnicak, Lesley; Dowdell, Kennichi C; Burbelo, Peter D; Knipe, David M; Straus, Stephen E; Cohen, Jeffrey I

NRAS mutation causes a human autoimmune lymphoproliferative syndrome

NRAS基因突变会导致人类自身免疫性淋巴增生综合征。

Oliveira, João B; Bidère, Nicolas; Niemela, Julie E; Zheng, Lixin; Sakai, Keiko; Nix, Cynthia P; Danner, Robert L; Barb, Jennifer; Munson, Peter J; Puck, Jennifer M; Dale, Janet; Straus, Stephen E; Fleisher, Thomas A; Lenardo, Michael J

Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.

由于与自身免疫性淋巴增生综合征(ALPS)Ib 型相关的杂合突变,导致 Fas 配体介导的细胞凋亡受到显性抑制

Bi Lilia L, Pan George, Atkinson T Prescott, Zheng Lixin, Dale Janet K, Makris Christopher, Reddy Vishnu, McDonald Jay M, Siegel Richard M, Puck Jennifer M, Lenardo Michael J, Straus Stephen E

Response to: "Rescuing the NIH before it is too late"

对“在为时已晚之前拯救美国国立卫生研究院”一文的回应

Alexander, Duane F; Alving, Barbara M; Battey, James F; Berg, Jeremy M; Collins, Francis S; Fauci, Anthony S; Gallin, John I; Grady, Patricia A; Hodes, Richard J; Hrynkow, Sharon H; Insel, Thomas R; Jones, Jack F; Katz, Stephen I; Landis, Story C; Li, Ting-Kai; Lindberg, Donald A; Nabel, Elizabeth G; Niederhuber, John E; Pettigrew, Roderic I; Rodgers, Griffin P; Ruffin, John; Scarpa, Antonio; Schwartz, David A; Sieving, Paul A; Straus, Stephen E; Tabak, Lawrence A; Volkow, Nora D

Getting it right: being smarter about clinical trials

做好临床试验:更明智地开展临床试验

Kramer, Barnett S; Wilentz, Joan; Alexander, Duane; Burklow, John; Friedman, Lawrence M; Hodes, Richard; Kirschstein, Ruth; Patterson, Amy; Rodgers, Griffin; Straus, Stephen E

Induction of apoptosis and activation of NF-kappaB by CD95 require different signalling thresholds

CD95诱导细胞凋亡和激活NF-κB需要不同的信号阈值。

Legembre, Patrick; Barnhart, Bryan C; Zheng, Lixin; Vijayan, Shrijay; Straus, Stephen E; Puck, Jennifer; Dale, Janet K; Lenardo, Michael; Peter, Marcus E